A preliminary study of tracking B-cell kinetics in patients with lung transplantation by monitoring kappa-deleting recombination excision circles.

B lymphocyte immune system kappa-deleting recombination excision circle lung transplantation

Journal

Turk gogus kalp damar cerrahisi dergisi
ISSN: 1301-5680
Titre abrégé: Turk Gogus Kalp Damar Cerrahisi Derg
Pays: Turkey
ID NLM: 100887967

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 01 03 2021
accepted: 31 08 2021
entrez: 6 1 2023
pubmed: 7 1 2023
medline: 7 1 2023
Statut: epublish

Résumé

This study aims to evaluate humoral immune system response by measuring copy numbers of kappa-deleting recombination excision circles (KREC) gene segment from B lymphocytes in patients with lung transplantation. Between September 2015 and November 2016, a total of 11 patients (8 males, 3 females; mean age: 45.4±12.0 years; range, 23 to 59 years) who underwent lung transplantation with different primary indications were included. The copy numbers of KREC gene segment were quantified using real-time polymerase chain reaction method in peripheral blood samples collected pre- and post-transplantation. The samples of the patients were compared with the KREC l evels i n deoxyribonucleic acid extracted from blood samples of healthy children. There was no significant change in KREC levels between pre- and post-operation (p=0.594 and p=0.657), although the median values indicated that the highest increase in the KREC levels (7x105- 12x105; 85-170) was on Day 7 of transplantation. There was a positive correlation between the KREC levels (mL in blood) and lymphocytes at 24 h after transplantation (p=0.043) and between KREC copies per 106 of blood and age on Day 7. Our preliminary results suggest that KREC l evels a s an indicator of B lymphocyte production are elevated after lung transplantation. A prognostic algorithm by tracking B cell kinetics after post-transplantation for long-term follow-up can be developed following the confirmation of these preliminary results with more patient samples.

Sections du résumé

Background UNASSIGNED
This study aims to evaluate humoral immune system response by measuring copy numbers of kappa-deleting recombination excision circles (KREC) gene segment from B lymphocytes in patients with lung transplantation.
Methods UNASSIGNED
Between September 2015 and November 2016, a total of 11 patients (8 males, 3 females; mean age: 45.4±12.0 years; range, 23 to 59 years) who underwent lung transplantation with different primary indications were included. The copy numbers of KREC gene segment were quantified using real-time polymerase chain reaction method in peripheral blood samples collected pre- and post-transplantation. The samples of the patients were compared with the KREC l evels i n deoxyribonucleic acid extracted from blood samples of healthy children.
Results UNASSIGNED
There was no significant change in KREC levels between pre- and post-operation (p=0.594 and p=0.657), although the median values indicated that the highest increase in the KREC levels (7x105- 12x105; 85-170) was on Day 7 of transplantation. There was a positive correlation between the KREC levels (mL in blood) and lymphocytes at 24 h after transplantation (p=0.043) and between KREC copies per 106 of blood and age on Day 7.
Conclusion UNASSIGNED
Our preliminary results suggest that KREC l evels a s an indicator of B lymphocyte production are elevated after lung transplantation. A prognostic algorithm by tracking B cell kinetics after post-transplantation for long-term follow-up can be developed following the confirmation of these preliminary results with more patient samples.

Identifiants

pubmed: 36605322
doi: 10.5606/tgkdc.dergisi.2022.21672
pmc: PMC9801467
doi:

Types de publication

Journal Article

Langues

eng

Pagination

611-621

Informations de copyright

Copyright © 2022, Turkish Society of Cardiovascular Surgery.

Déclaration de conflit d'intérêts

Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Auteurs

Zeynep Akbulut (Z)

Maltepe University, Cancer and Stem Cell Research Center, Istanbul, Türkiye.

Tuba Akdeniz (T)

Department of Molecular Medicine, Yeditepe University Hospital, Istanbul, Türkiye.

Mustafa Vayvada (M)

Department of Thoracic Surgery, Kartal Koşuyolu High Specialization Education and Research Hospital, Istanbul, Türkiye.

Merih Kalamanoğlu (M)

Department of Chest Diseases and Tuberculosis, Bahçeşehir University Hospital, Medical Park Göztepe, Istanbul, Türkiye.

Ali Yeğinsu (A)

Department of Thoracic Surgery, Yeni Yüzyıl University Hospital, Istanbul, Türkiye.

Gülderen Yanıkkaya Demirel (G)

Department of Immunology, Yeditepe University Hospital, Istanbul, Türkiye.

Cemal Asım Kutlu (CA)

Department of Thoracic Surgery, Bahçeşehir University Hospital, Medical Park Göztepe, Istanbul, Türkiye.

Classifications MeSH